RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ACOR
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

FAQ

What is the symbol for Acorda Therapeutics Stock and on which exchange is it traded?
The symbol for Acorda Therapeutics is ACOR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Acorda Therapeutics Stock?
Acorda Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Acorda Therapeutics Stock?
Acorda Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Acorda Therapeutics Stock.

What's the current price of Acorda Therapeutics Stock?
As of the end of day on the Jul 02, 2024, the price of an Acorda Therapeutics (ACOR) share was $0.661.

What is the 52-week high and low for Acorda Therapeutics Stock?
The 52-week high for Acorda Therapeutics Stock is $18.21 and the 52-week low is $0.612.

What is the market capitalization of Acorda Therapeutics Stock?
As of the Jul 02, 2024, the market capitalization of Acorda Therapeutics is 821.028K.

When is the next earnings date for Acorda Therapeutics?
The upcoming earnings date for Acorda Therapeutics is Aug 06, 2024.
Click to get the best stock tips daily for free!

About Acorda Therapeutics

Acorda Therapeutics Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops ARCUS p... ACOR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT